國家衛生研究院 NHRI:
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12500/13673 (91%)
Visitors : 2618726      Online Users : 404
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version

    Collection

    Patents [0/70]
    Periodical Articles [161/161]
    Conference Papers/Meeting Abstract [23/37]

    Community Statistics


    Item counts issued in 3 years:28(10.45%)
    Items With Fulltext:184(68.66%)

    Download counts of the item
    Download times greater than 0:184(100.00%)
    Download times greater than 100:178(96.74%)
    Total Bitstream Download Counts:103006(1.76%)

    Last Update: 2025-04-29 10:09

    Top Upload

    Loading...

    Top Download

    Loading...

    RSS Feed RSS Feed
    Jump to a point in the index:
    Or type in a year:
    Ordering With Most Recent First Show Oldest First

    Showing items 1-25 of 268. (11 Page(s) Totally)
    1 2 3 4 5 6 7 8 9 10 > >>
    View [10|25|50] records per page

    DateTitleRelation
    2025-02-27 Orally bioavailable and site-selective covalent STING inhibitor derived from a macrocyclic marine diterpenoid Journal of Medicinal Chemistry. 2025 Feb 27;Article in Press.
    2025-02 Natural fucoidans inhibit coronaviruses by targeting viral spike protein and host cell furin[Erratum:Biochemical Pharmacology. 2023 Jul 20;215:Article number 115688.] Biochemical Pharmacology. 2025 Feb;232:Article number 116753.
    2025-01-05 Integrating ultrabright polymer dots and stereo NIR-II imager for assessing anti-angiogenic drugs in oral cancer model Journal of Cellular and Molecular Medicine. 2025 Jan 05;29(1):Article number e70324.
    2025-01 Advancing precision therapy for colorectal cancer: Developing clinical indications for multi-target kinase inhibitor BPR1J481 using patient-derived xenograft models Pharmacological Research. 2025 Jan;211:Article number 107556.
    2024-11-21 Discovery of a mu-opioid receptor modulator that in combination with morphinan antagonists induces analgesia Cell Chemical Biology. 2024 Nov 21;31(11):1885-1898.e10.
    2024-11 DBPR116, a prodrug of BPRMU191, in combination with naltrexone as a safer opioid analgesic than morphine via peripheral administration Journal of Medicinal Chemistry. 2024 Nov 14;67(21):19777-19790.
    2024-06-01 Discovery of a long half-life AURKA inhibitor to treat MYC-amplified solid tumors as a monotherapy and in combination with everolimus Molecular Cancer Therapeutics. 2024 Jun 01;23(6):766-779.
    2024-05-30 Poly heterocyclic conjugates and their pharmaceutical uses ZA2022/12959/2024-05-30
    2024-03-26 Heterocyclic compounds and use thereof NZ730195/2024-03-26
    2024-02-16 Postfermented tea extract potently alleviates glucose metabolism disorders in vitro and in vivo ACS Food Science and Technology. 2024 Feb 16;4(2):479-490.
    2024-01-23 Poly heterocyclic conjugates and their pharmaceutical uses US11878986/2024-01-23
    2024-01-14 Benzimidazole compounds and use thereof for treating alzheimer's disease or huntington's disease SG11202101274X/2024-01-14
    2023-12-19 Heterocyclic compounds and use thereof CA2962329/2023-12-19
    2023-09-26 Composto de fórmula (i) e composição farmacêutica BR112017005713/2023-09-26
    2023-08-31 Dipicolylamine derivatives and their pharmaceutical uses IN448770/2023-08-31
    2023-08-15 Composto e composição farmacêutica BR112016027078-9/2023-08-15
    2023-07-20 Natural fucoidans inhibit coronaviruses by targeting viral spike protein and host cell furin Biochemical Pharmacology. 2023 Jul 20;215:Article number 115688.
    2023-06-01 增加細胞吞噬作用之方法 TWI804339/2023-06-01
    2023-04-21 多雜環小分子藥物偶合物及其用途 TWI799896/2023-04-21
    2023-03-08 헤테로사이클릭 화합물과 이의 용도 KR10-2509431/2023-03-08
    2023-03-03 Benzimidazole compounds and use thereof for treating alzheimer's disease or huntington's disease IN424040/2023-03-03
    2023-02-10 Heterocyclic compounds and use thereof IN421151/2023-02-10
    2023-02-07 Development of furanopyrimidine-based orally active third-generation EGFR inhibitors for the treatment of non-small cell lung cancer Journal of Medicinal Chemistry. 2023 Feb 7;66(4):2566-2588.
    2023-01-27 苯並咪唑化合物及其在製備治療阿茲海默症或亨丁頓氏症的藥物中的用途 HK40053325/2023-01-27
    2023-01-26 苯并咪唑化合物及其在製備治療阿茲海默症或亨丁頓氏症的藥物中的用途 J/006659/2023-01-26

    Showing items 1-25 of 268. (11 Page(s) Totally)
    1 2 3 4 5 6 7 8 9 10 > >>
    View [10|25|50] records per page

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback